In addition, they have a specific antidote and are therefore less likely to cause death by overdose. Hypnotics may have become safer, but their use in Taiwan has also grown rapidly in recent years. The new short-acting non-benzodiazepine hypnotics containing Zolpidem, which binds to BZD-1 receptors in the cerebellum, account for nearly half of these.
雖然安全性增加，但台灣近年安眠鎮定劑類用藥快速增加，其中近半是所謂新型態、短效型（幫助快速入睡，持續作用時間少於 6 小時）、主要作用於小腦中 BZD- 1 接受器的非苯二氮平類、含佐沛眠成分的安眠藥。